@article{BrehonyTrotterRamsayetal.2014,
  author    = {Brehony, Carina and Trotter, Caronline L. and Ramsay, Mary E. and Chandra, Manosree and Jolley, Keith A. and van der Ende, Arie and Carion, Fran{\c{c}}oise and Berthelsen, Lene and Hoffmann, Steen and Harðard{\´o}ttir, Hj{\"o}rd{\´i}s and Vazques, Julio A. and Murphy, Karen and Toropainen, Maija and Cani{\c{c}}a, Manuela and Ferreira, Eugenia and Diggle, Mathew and Edwards, Giles F. and Taha, Muhamed-Kheir and Stefanelli, Paola and Kriz, Paula and Gray, Steve J. and Fox, Andrew J. and Jacobsson, Susanne and Claus, Heike and Vogel, Ulrich and Tzanakaki, Georgina and Heuberger, Sigrid and Caugant, Dominique A. and Frosch, Matthias and Maiden, Martin C. J.},
  title     = {Implications of Differential Age Distribution of Disease-Associated Meningococcal Lineages for Vaccine Development},
  series = {Clinical and Vaccine Immunology : CVI},
  volume    = {21},
  journal   = {Clinical and Vaccine Immunology : CVI},
  number    = {6},
  doi       = {10.1128/cvi.00133-14},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-120808},
  pages     = {847-53},
  year      = {2014},
  abstract  = {New vaccines targeting meningococci expressing serogroup B polysaccharide have been developed, with some being licensed in Europe. Coverage depends on the distribution of disease-associated genotypes, which may vary by age. It is well established that a small number of hyperinvasive lineages account for most disease, and these lineages are associated with particular antigens, including vaccine candidates. A collection of 4,048 representative meningococcal disease isolates from 18 European countries, collected over a 3-year period, were characterized by multilocus sequence typing (MLST). Age data were available for 3,147 isolates. The proportions of hyperinvasive lineages, identified as particular clonal complexes (ccs) by MLST, differed among age groups. Subjects <1 year of age experienced lower risk of sequence type 11 (ST-11) cc, ST-32 cc, and ST-269 cc disease and higher risk of disease due to unassigned STs, 1- to 4-year-olds experienced lower risk of ST-11 cc and ST-32 cc disease, 5- to 14-year-olds were less likely to experience ST-11 cc and ST-269 cc disease, and ≥25-year-olds were more likely to experience disease due to less common ccs and unassigned STs. Younger and older subjects were vulnerable to a more diverse set of genotypes, indicating the more clonal nature of genotypes affecting adolescents and young adults. Knowledge of temporal and spatial diversity and the dynamics of meningococcal populations is essential for disease control by vaccines, as coverage is lineage specific. The nonrandom age distribution of hyperinvasive lineages has consequences for the design and implementation of vaccines, as different variants, or perhaps targets, may be required for different age groups.},
  language  = {en}
}
@article{HarrisonClausJiangetal.2013,
  author    = {Harrison, Odile B. and Claus, Heike and Jiang, Ying and Bennett, Julia S. and Bratcher, Holly B. and Jolley, Keith A. and Corton, Craig and Care, Rory and Poolman, Jan T. and Zollinger, Wendell D. and Frasch, Carl E. and Stephens, David S. and Feavers, Ian and Frosch, Matthias and Parkhill, Julian and Vogel, Ulrich and Quail, Michael A. and Bentley, Stephen D. and Maiden, Martin C. J.},
  title     = {Description and Nomenclature of Neisseria meningitidis Capsule Locus},
  series = {Emerging Infectious Diseases},
  volume    = {19},
  journal   = {Emerging Infectious Diseases},
  number    = {4},
  doi       = {10.3201/eid1904.111799},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-131703},
  pages     = {566-573},
  year      = {2013},
  abstract  = {Pathogenic Neisseria meningitidis isolates contain a polysaccharide capsule that is the main virulence determinant for this bacterium. Thirteen capsular polysaccharides have been described, and nuclear magnetic resonance spectroscopy has enabled determination of the structure of capsular polysaccharides responsible for serogroup specificity. Molecular mechanisms involved in N. meningitidis capsule biosynthesis have also been identified, and genes involved in this process and in cell surface translocation are clustered at a single chromosomal locus termed cps. The use of multiple names for some of the genes involved in capsule synthesis, combined with the need for rapid diagnosis of serogroups commonly associated with invasive meningococcal disease, prompted a requirement for a consistent approach to the nomenclature of capsule genes. In this report, a comprehensive description of all N. meningitidis serogroups is provided, along with a proposed nomenclature, which was presented at the 2012 XVIIIth International Pathogenic Neisseria Conference.},
  language  = {en}
}
@article{MaidenFrosch2012,
  author    = {Maiden, Martin C. J. and Frosch, Matthias},
  title     = {Can we, should we, eradicate the meningococcus?},
  series = {Vaccine},
  volume    = {30},
  journal   = {Vaccine},
  number    = {Suppl. 2},
  doi       = {10.1016/j.vaccine.2011.12.068},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-125646},
  pages     = {B52-B56},
  year      = {2012},
  abstract  = {The eradication of infectious agents is an attractive means of disease control that, to date, has been achieved for only one human pathogen, the smallpox virus. The introduction of vaccines against Neisseria meningitidis into immunisation schedules, and particularly the conjugate polysaccharide vaccines which can interrupt transmission, raises the question of whether disease caused by this obligate human bacterium can be controlled, eliminated, or even eradicated. The limited number of meningococcal serogroups, lack of an animal reservoir, and importance of meningococcal disease are considerations in favour of eradication; however, the commensal nature of most infections, the high diversity of meningococcal populations, and the lack of comprehensive vaccines are all factors that suggest that this is not feasible. Indeed, any such attempt might be harmful by perturbing the human microbiome and its interaction with the immune system. On balance, the control and possible elimination of disease caused by particular disease-associated meningococcal genotypes is a more achievable and worthwhile goal.},
  language  = {en}
}